← FDA DRUG APPROVALS

FDA ANDA · ANDA210004

CLINDAMYCIN PHOSPHATE

Sponsor: TARO

APPLICATION
ANDA210004
TYPE
ANDA
ORIGINAL APPROVAL
2020-03-11
LATEST ACTION
2020-03-11
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, FOAM
MARKETING STATUS
Prescription

Products

CLINDAMYCIN PHOSPHATEPrescription
CLINDAMYCIN PHOSPHATE 1% · AEROSOL, FOAM · TOPICAL

Approval history

2020-03-11UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →